|
Cannabis Campaigners' Guide News Database result:
|
|
UK: Cancer patients to test cannabis spray
Lorna Duckworth The Independent
Thursday 17 Jan 2002 Patients in uncontrollable pain from terminal cancer are to be treated with cannabis-based medicines as part of trials launched. The cannabis extracts, which are sprayed under the tongue, are already being tested on people with multiple sclerosis (MS) as part of phase-three trials - the last stage before approval by the Medicines Control Agency. If the success of earlier experiments is repeated, an application to license the medicines for patients with MS, cancer and spinal cord damage could be made next year. GW Pharmaceuticals, which specialises in cannabis-based medicines, said more than 100 patients with terminal cancer would take part in the study at more than 20 centres. The company, which is based at Porton Down near Salisbury, grows special strains of cannabis at secret locations. Preliminary results from phase-two trials on MS patients and those with spinal injuries, announced yesterday, showed significant improvements in a range of symptoms. Dr Geoffrey Guy, executive chairman of the company, said 40 per cent of cancer patients did not get relief from opiates such as morphine, and half of these had pain which could not be controlled by any licensed medicines. "Cannabis-based medicine has the potential to provide considerable advantages over current medications to cancer patients," he said. The company is also treating patients with brachial plexus injury, a form of nerve-damage pain that often results from motorcycle accidents.
After you have finished reading this article you can click here to go back.
|
This page was created by the Cannabis Campaigners' Guide.
Feel free to link to this page!